Doctors in Cambridge believe they are “on the brink of a new class of treatments” for multiple sclerosis (MS) after a trial in patients suggested nerve damage may be repaired.
The treatment involves combining the common diabetes drug, metformin, with clemastine, an antihistamine, to help repair myelin.
